Table 1.
Cancer cell line | Human tissue | Body fluids/plasma | |
---|---|---|---|
Advantages | Low cost | High physiological/pathological relevance | Low cost |
Renewable source | High physiological/pathological relevance | ||
Easy for gene manipulation | Easy to obtain from patients/ renewable source | ||
Good for mechanistic investigation | |||
Disadvantages | Require validation for physiological/pathological relevance | Higher cost | Higher protein complexity |
Clonal selection | Limited availability | High dynamic range in protein concentrations | |
Non‐renewable source | |||
Large variations among samples |